Coverage
-
July 19, 2018
Genentech Inc. told a New York federal judge Wednesday that it was dropping its suit seeking documents from White & Case LLP that would help it fight an effort by Samsung Bioepis Co. Ltd. to sell a drug in Europe that would compete with its blockbuster cancer drug Herceptin.
1 other articles on this case.
View all »